February 2015 Dendreon Was acquired by Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals) for roughly \\(\\$415\\) million net of cash.\nJune 2017 Sanpower Group acquired Dendreon from Valeant for \\(\\$820\\) million in cash.\nAugust 2018 Sanpower Group resold Dendreon to its publicly-traded retail and healthcare subsidiary, Nanjing Cenbest.